[1] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南. 临床肝胆病杂志, 2017, 33:158-174.
[2] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol, 2018, 69: 406-460.
[3] Abdel-Razik A, Eldars W, Elhelaly R, et al. Homocysteine: a new diagnostic marker in spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol, 2018, 30: 779-785.
[4] 杨丽霞, 张伦理, 赖玲玲, 等. 腹水中肝素结合蛋白及降钙素原对肝硬化腹水伴自发性细菌性腹膜炎的诊断价值. 临床肝胆病杂志, 2019, 35: 1266-1269.
[5] Abu Rahma MZ, Mahran ZG, Shafik EA, et al. The role of serum procalcitonin level as an early marker of ascitic fluid infection in post hepatitic cirrhotic patients. Antiinflamm Antiallergy Agents Med Chem, 2021, 20:61-67.
[6] Wu H, Chen L, Sun Y, et al. The role of serum procalcitonin and C-reactive protein levels in predicting spontaneous bacterial peritonitis in patients with advanced liver cirrhosis. Pakistan journal of medical sciences, 2016, 32: 1484-1488.
[7] Sabra S, Agwa MM. Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications. Int J Biol Macromol, 2020, 164: 1046-1060.
[8] Parsi MA, Saadeh SN, Zein NN, et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology, 2008, 135: 803-807.
[9] Lee SS, Min HJ, Choi JY, et al. Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis. BMC Gastroenterol, 2016, 16: 132.
[10] Weil D, Heurgue-Berlot A, Monnet E, et al. Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis. Hepatol Res, 2019, 49: 72-81.
[11] Bender MH, Hartmann L, Anemüller JR, et al. Calprotectin as diagnostic marker for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Clin Lab, 2020, 66.
[12] Abdel-Razik A, Mousa N, Elhammady D, et al. Ascitic fluid calprotectin and serum procalcitonin as accurate diagnostic markers for spontaneous bacterial peritonitis. Gut and liver, 2016, 10: 624-631.
[13] Nasereslami M, Khamnian Z, Moaddab Y, et al. Diagnostic and prognostic role of ascitic fluid calprotectin level: six-month outcome findings in cirrhotic patients. Scand J Gastroenterol, 2020,55:1093-1098.
[14] 余贻汉, 赵莉, 黄景荣, 等. 腹水钙卫蛋白含量对肝硬化自发性细菌性腹膜炎的诊断评价.中华医院感染学杂志, 2015, 25: 4128-4130.
[15] Zuwala-Jagiello J, Pazgan-Simon M, Simon K, et al. Serum endocan level in diabetes mellitus of patients with cirrhosis and risk of subsequent development of spontaneous bacterial peritonitis. J Physiol Pharmacol, 2019, 70.
[16] Zuwala-Jagiello J, Simon K, Kukla M, et al. Increased circulating endocan in patients with cirrhosis: relation to bacterial infection and severity of disease. J Physiol Pharmacol, 2017, 68: 273-282.
[17] Wu X, Luo J, Huang W, et al. Role of ascitic endocan levels in the diagnosis of spontaneous bacterial peritonitis in decompensated cirrhosis. Biomarkers, 2020, 25: 360-366.
[18] Cullaro G, Kim G, Pereira MR, et al. Ascites neutrophil gelatinase-associated lipocalin identifies spontaneous bacterial peritonitis and predicts mortality in hospitalized patients with cirrhosis. Dig Dis Sci, 2017, 62: 3487-3494.
[19] Liu H, Zhu P, Nie C, et al. The value of ascitic neutrophil gelatinase-associated lipocalin in decompensated liver cirrhosis with spontaneous bacterial peritonitis. J Clin Lab Anal, 2020, 34: e23247.
[20] Fouad TR, Abdelsameea E, Elsabaawy M, et al. Urinary neutrophil gelatinase-associated lipocalin for diagnosis of spontaneous bacterial peritonitis. Trop Doct, 2019, 49: 189-192.
[21] Yi A, Lee CH, Yun YM, et al. Effectiveness of plasma and urine neutrophil gelatinase-associated lipocalin for predicting acute kidney injury in high-risk patients. Ann Lab Med, 2021, 41: 60-67.
[22] 葛玲, 吴丽颖. 中性粒细胞明胶酶相关脂质运载蛋白在急性胰腺炎中的应用. 检验医学, 2020, 35: 420-423.
[23] Abdel-Razik A, Mousa N, Elbaz S, et al. Diagnostic utility of interferon gamma-induced protein 10 kDa in spontaneous bacterial peritonitis: single-center study. Eur J Gastroenterol Hepatol, 2015, 27: 1087-1093.
[24] Badawi R, Asghar MN, Abd-Elsalam S, et al. Amyloid A in serum and ascitic fluid as a novel diagnostic marker of spontaneous bacterial peritonitis. Antiinflamm Antiallergy Agents Med Chem, 2020, 19: 140-148.
[25] 陈祥飞, 徐维田, 程翌, 等. SAA、LPS及PCT对肝硬化合并自发性细菌性腹膜炎的诊断特异性和敏感性分析. 中国医学前沿杂志(电子版), 2019, 11: 91-94.
[26] Nabiel Y, Barakat G, Abed S. Serum CD64 and ascitic fluid calprotectin and microRNA-155 as potential biomarkers of spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol, 2019, 31: 1064-1069.
[27] Wang H, Li Y, Zhang F, et al. Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients. BMC Infect Dis, 2018, 18: 389. |
